Joshua T Slysz1, Jamie F Burr2. 1. Department of Human Health and Nutritional Sciences, University of Guelph, ANNU Building, 50 Stone Rd East, Guelph, ON, N1G 2W1, Canada. 2. Department of Human Health and Nutritional Sciences, University of Guelph, ANNU Building, 50 Stone Rd East, Guelph, ON, N1G 2W1, Canada. burrj@uoguelph.ca.
Abstract
PURPOSE: To examine if repeated exposure to IPC treatment prior to training sessions improves oxygen uptake and 1-km running performance in highly trained middle-distance runners. METHODS:Fourteen highly trained endurance runners (11 male/3 female, 19 ± 2 years, 64 ± 5 ml kg-1 min-1) completed a baseline maximal oxygen consumption ([Formula: see text]) test and 1-km running performance test before random assignment to an IPC or control group. Both groups were prescribed identical endurance training over an 8-week varsity season; however, the IPC group performed an IPC protocol (5 min ischemia, repeated 3 times, each separated by 5 min reperfusion) before every training session. After 8 weeks of training, participants completed a follow-up [Formula: see text] test and 1-km time trial. RESULTS: [Formula: see text] did not increase from baseline in either group following the 8-week training bout (P = 0.2), and neither group varied more than the other ([Formula: see text] = IPC 0.6 ± 2 ml kg-1 min-1; control 1.5 ± 2 ml kg-1 min-1, P = 0.6) or beyond typical measurement error. The IPC decreased 1-km time trial time by 0.4% (0.5 ± 2 s), while the control group decreased by 1% (1.5 ± 3 s), but neither change was significant compared to baseline (P = 0.2). There was also no difference in time trial improvement between IPC and control (P = 0.6). However, there was a trend towards IPC significantly improving running economy at low intensity (P = 0.057). CONCLUSION: Our data suggest that over a normal 8-week season in a population of highly trained middle-distance runners there is no benefit of undergoing chronic, repeated IPC treatments before training for augmenting maximal aerobic power or 1-km performance time.
RCT Entities:
PURPOSE: To examine if repeated exposure to IPC treatment prior to training sessions improves oxygen uptake and 1-km running performance in highly trained middle-distance runners. METHODS: Fourteen highly trained endurance runners (11 male/3 female, 19 ± 2 years, 64 ± 5 ml kg-1 min-1) completed a baseline maximal oxygen consumption ([Formula: see text]) test and 1-km running performance test before random assignment to an IPC or control group. Both groups were prescribed identical endurance training over an 8-week varsity season; however, the IPC group performed an IPC protocol (5 min ischemia, repeated 3 times, each separated by 5 min reperfusion) before every training session. After 8 weeks of training, participants completed a follow-up [Formula: see text] test and 1-km time trial. RESULTS: [Formula: see text] did not increase from baseline in either group following the 8-week training bout (P = 0.2), and neither group varied more than the other ([Formula: see text] = IPC 0.6 ± 2 ml kg-1 min-1; control 1.5 ± 2 ml kg-1 min-1, P = 0.6) or beyond typical measurement error. The IPC decreased 1-km time trial time by 0.4% (0.5 ± 2 s), while the control group decreased by 1% (1.5 ± 3 s), but neither change was significant compared to baseline (P = 0.2). There was also no difference in time trial improvement between IPC and control (P = 0.6). However, there was a trend towards IPC significantly improving running economy at low intensity (P = 0.057). CONCLUSION: Our data suggest that over a normal 8-week season in a population of highly trained middle-distance runners there is no benefit of undergoing chronic, repeated IPC treatments before training for augmenting maximal aerobic power or 1-km performance time.
Authors: Emilie Jean-St-Michel; Cedric Manlhiot; Jing Li; Michael Tropak; Marie M Michelsen; Michael R Schmidt; Brian W McCrindle; Greg D Wells; Andrew N Redington Journal: Med Sci Sports Exerc Date: 2011-07 Impact factor: 5.411
Authors: T C Barbosa; A C Machado; I D Braz; I A Fernandes; L C Vianna; A C L Nobrega; B M Silva Journal: Scand J Med Sci Sports Date: 2014-04-15 Impact factor: 4.221
Authors: Helen Jones; Nicola Hopkins; Tom G Bailey; Daniel J Green; N Timothy Cable; Dick H J Thijssen Journal: Am J Hypertens Date: 2014-03-13 Impact factor: 2.689
Authors: Jacob Johnsen; Kasper Pryds; Rasha Salman; Bo Løfgren; Steen Buus Kristiansen; Hans Erik Bøtker Journal: Basic Res Cardiol Date: 2016-01-14 Impact factor: 17.165
Authors: Thomas Kjeld; Mads Reinholdt Rasmussen; Timo Jattu; Henning Bay Nielsen; Niels Henry Secher Journal: Med Sci Sports Exerc Date: 2014-01 Impact factor: 5.411
Authors: Patricia C E de Groot; Dick H J Thijssen; Manuel Sanchez; Reinier Ellenkamp; Maria T E Hopman Journal: Eur J Appl Physiol Date: 2009-09-18 Impact factor: 3.078
Authors: Angus Lindsay; Carl Petersen; Gavin Blackwell; Hamish Ferguson; Greg Parker; Nina Steyn; Steven P Gieseg Journal: BMJ Open Sport Exerc Med Date: 2017-05-31